Extends the authority to award priority review vouchers for rare pediatric disease products.
The Priority for Pediatric Cures Act amends the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products. This change aims to ensure ongoing support for the development of treatments for rare diseases affecting children.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.